478 related articles for article (PubMed ID: 27595886)
1. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy.
Medeiros P; de Freitas RL; Silva MO; Coimbra NC; Melo-Thomas L
Neuroscience; 2016 Nov; 337():17-26. PubMed ID: 27595886
[TBL] [Abstract][Full Text] [Related]
2. L-NOARG-induced catalepsy can be influenced by glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus.
Iacopucci AP; Mello RO; Barbosa-Silva R; Melo-Thomas L
Behav Brain Res; 2012 Oct; 234(2):149-54. PubMed ID: 22749845
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy.
Medeiros P; Viana MB; Barbosa-Silva RC; Tonelli LC; Melo-Thomas L
Behav Brain Res; 2014 Jul; 268():8-13. PubMed ID: 24667361
[TBL] [Abstract][Full Text] [Related]
4. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
[TBL] [Abstract][Full Text] [Related]
5. Modulation of haloperidol-induced catalepsy in rats by GABAergic neural substrate in the inferior colliculus.
Tostes JG; Medeiros P; Melo-Thomas L
Neuroscience; 2013; 255():212-8. PubMed ID: 24125891
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
7. CB
Dos Anjos-Garcia T; Ullah F; Falconi-Sobrinho LL; Coimbra NC
Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical kinesia induced by appetitive 50-kHz ultrasonic vocalizations in rats depends on glutamatergic mechanisms in the inferior colliculus.
Tonelli LC; Wöhr M; Schwarting R; Melo-Thomas L
Neuropharmacology; 2018 Jun; 135():172-179. PubMed ID: 29550392
[TBL] [Abstract][Full Text] [Related]
9. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
[TBL] [Abstract][Full Text] [Related]
10. Pre-training anandamide infusion within the basolateral amygdala impairs plus-maze discriminative avoidance task in rats.
Munguba H; Cabral A; Leão AH; Barbosa FF; Izídio GS; Ribeiro AM; Silva RH
Neurobiol Learn Mem; 2011 May; 95(4):527-33. PubMed ID: 21440651
[TBL] [Abstract][Full Text] [Related]
11. Protective role of endocannabinoid signaling in an animal model of haloperidol-induced tardive dyskinesia.
Röpke J; Ferreira-Vieira TH; Iglesias LP; Asth L; Ribeiro FM; Moreira FA
Pharmacol Biochem Behav; 2021 Jul; 206():173193. PubMed ID: 33933537
[TBL] [Abstract][Full Text] [Related]
12. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
14. Anandamide reduces the ejaculatory threshold of sexually sluggish male rats: possible relevance for human lifelong delayed ejaculation disorder.
Rodríguez-Manzo G; Canseco-Alba A
J Sex Med; 2015 May; 12(5):1128-35. PubMed ID: 25808995
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of haloperidol in the mediation of conditioned fear in the mesolimbic system and processing of unconditioned aversive information in the inferior colliculus.
Muthuraju S; Nobre MJ; Saito VM; Brandao ML
Neuroscience; 2014 Mar; 261():195-206. PubMed ID: 24384225
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC
J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884
[TBL] [Abstract][Full Text] [Related]
17. Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion.
Ruginsk SG; Uchoa ET; Elias LL; Antunes-Rodrigues J
Clin Exp Pharmacol Physiol; 2013 Oct; 40(10):698-705. PubMed ID: 23875874
[TBL] [Abstract][Full Text] [Related]
18. Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart.
Li Q; Shi M; Li B
J Physiol Sci; 2013 Jan; 63(1):47-53. PubMed ID: 23007622
[TBL] [Abstract][Full Text] [Related]
19. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M
Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666
[TBL] [Abstract][Full Text] [Related]
20. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
